Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Essai de Phase IV, Multicentrique, Ouvert, Visant à Tester la différence d'efficacité du Natalizumab, Versus le Fingolimod, 2 médicaments Ayant Une AMM Pour le Traitement de la sclérose en Plaques

NCT01981161 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT01981161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01981161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Essai de Phase IV, Multicentrique, Ouvert, Visant à Tester la différence d'efficacité du Natalizumab, Versus le Fingolimod, 2 médicaments Ayant Une AMM Pour le Traitement de la sclérose en Plaques
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Completed
Start date
November 19, 2013
Completion date
November 30, 2018
Enrollment
307 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis